4 Houston innovators to know this week

who's who

This week's roundup of Houston innovators includes Grant Watkins and Keely McEnery of Earn Your Freedom, Richard Seline of the Resilience Manufacturing Hub, and Tim Latimer of Fervo Energy. Photos courtesy

Editor's note: In this week's roundup of Houston innovators to know, I'm introducing you to four local innovators across industries — from financial edtech to geothermal energy — recently making headlines in Houston innovation.

Grant Watkins and Keely McEnery, co-founders of Earn Your Freedom

Grant Watkins and Keely McEnery, co-founders of Earn Your Freedom, join the Houston Innovators Podcast. Photos courtesy of EYF

Houston-based Earn Your Freedom combines edtech, fintech, and gaming, as the co-founders, Grant Watkins and Keely McEnery explain on last week's episode of the Houston Innovators Podcast.

Both Watkins and McEnery have overcome personal finance obstacles, as they share on the show, and they aren't alone. Sixty-seven percent of Americans are considered financially illiterate, McEnery says, and 60 percent lives paycheck to paycheck.

"It's becoming more and more apparent how financially illiterate our country is," she continues. "It's a different mindset. People could be making $100,000 a year but if they don't know how to manage their money, they're still going to be in a cycle of not being financially free."

EYF's solution is a comprehensive, entertaining way for high school students to learn. And the timing is great, since Texas recently passed a bill about providing financial literacy education in high schools. Read more.

Richard Seline, co-founder and managing director of the Resilience Innovation Hub

A 130,000-square-foot Resilience Manufacturing Hub is coming to the Second Ward. Photo courtesy

Houston will soon have a 130,000-square-foot Resilience Manufacturing Hub that will house functions such as R&D, manufacturing, and assembly for products aimed at improving the resilience of homes, office buildings, warehouses, and other components of the “built environment.”

“We are looking for any product or technology solution that can reduce the impact from the next generation of disasters … by helping people thrive, not just survive, in their own community,” says Richard Seline, co-founder and managing director of the Houston-based Resilience Innovation Hub. The innovation hub is a partner in the manufacturing hub.

Seline says the manufacturing hub, with an estimated price tag of $32 million, will directly employ about 60 people. He expects the facility to either generate or “upskill” about 240 off-site jobs. Read more.

Tim Latimer, CEO and co-founder of Fervo Energy

Houston-based Fervo Energy shared the results of its commercial pilot project with Google. Photo via LinkedIn

Houston-based Fervo Energy announced this week that its commercial pilot project has resulted in continuous carbon-free geothermal energy production. The full-scale commercial pilot, Project Red, is in northern Nevada and made possible through a 2021 partnership with Google.

“By applying drilling technology from the oil and gas industry, we have proven that we can produce 24/7 carbon-free energy resources in new geographies across the world," Tim Latimer, Fervo Energy CEO and co-founder, says in a news release. "The incredible results we share today are the product of many years of dedicated work and commitment from Fervo employees and industry partners, especially Google." Read more.

From Your Site Articles
Grant Watkins and Keely McEnery, co-founders of Earn Your Freedom, join the Houston Innovators Podcast. Photos courtesy of EYF

Why these Houston founders are gamifying financial literacy education

HOUSTON INNOVATORS PODCAST EPISODE 195

Houston co-founders Grant Watkins and Keely McEnery are a team when it comes to building their business — but the two are locked into a very serious competition on their phones.

"Keeley and I are both avid users of Duolingo which is, in my opinion, still the best like best example of gamification for education," Watkins says on this week's episode of the Houston Innovators Podcast.

"Just the simple 'keep your streak alive,'" he explains, adding that he's recently crossed the one-year mark of daily participation, "it keeps me incentivized to keep my street going. I don't even want to learn Spanish anymore. I just want to I just don't want to lose to Keely."

Watkins is inspired by the app — not only to learn a foreign language, but to apply a similar gamification to financial literacy. He learned to code in 2021 and founded Earn Your Freedom, launching the Money Quest game in April after bringing on McEnery, a business student at the University of Houston, as co-founder and COO.

Both Watkins and McEnery have overcome personal finance obstacles, as they share on the show, and they aren't alone. Sixty-seven percent of Americans are considered financially illiterate, McEnery says, and 60 percent lives paycheck to paycheck.

"It's becoming more and more apparent how financially illiterate our country is," she continues. "It's a different mindset. People could be making $100,000 a year but if they don't know how to manage their money, they're still going to be in a cycle of not being financially free."

EYF's solution is a comprehensive, entertaining way for high school students to learn. And the timing is great, since Texas recently passed a bill about providing financial literacy education in high schools.

"Texas is not alone in this. There are actually 23 other states that have recently either passed or in the process of passing financial literacy bills, and most of them are aimed at high schools," Watkins explains. "I do believe high school is kind of the last best opportunity to teach them. When we're traveling around the state and talking to these kids, we're seeing the juniors and seniors in high school very engaged with this information."

The duo, which originally connected at the Ion and volunteering with the G-Unity Foundation, has tapped into the Houston innovation ecosystem to help grow their network and connections to do more of the game's testing in Houston schools. Most recently, EYF announced its first crowdfunding campaign with the support of Impact Hub Houston, a community supporting impact-driven startups and opportunities. The campaign, launched online earlier this month, is seeking $100,000 to further expand its testing in students.

Watkins and McEnery share more about the game, their plans for the business, and more on the podcast. Listen to the interview below — or wherever you stream your podcasts — and subscribe for weekly episodes.


Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Property Showcase

Greentown Labs names Lawson Gow as its new Houston leader

head of hou

Greentown Labs has named Lawson Gow as its Head of Houston.

Gow is the founder of The Cannon, a coworking space with seven locations in the Houston area, with additional partner spaces. He also recently served as managing partner at Houston-based investment and advisory firm Helium Capital. Gow is the son of David Gow, founder of Energy Capital's parent company, Gow Media.

According to Greentown, Gow will "enhance the founder experience, cultivate strategic partnerships, and accelerate climatetech solutions" in his new role.

“I couldn’t be more excited to join Greentown at this critical moment for the energy transition,” Gow said in a news release. “Greentown has a fantastic track record of supporting entrepreneurs in Houston, Boston, and beyond, and I am eager to keep advancing our mission in the energy transition capital of the world.”

Gow has also held analyst, strategy and advising roles since graduating from Rice University.

“We are thrilled to welcome Lawson to our leadership team,” Georgina Campbell Flatter, CEO of Greentown Labs, added in the release. “Lawson has spent his career building community and championing entrepreneurs, and we look forward to him deepening Greentown’s support of climate and energy startups as our Head of Houston.”

Gow is the latest addition to a series of new hires at Greentown Labs following a leadership shakeup.

Flatter was named as the organization's new CEO in February, replacing Kevin Dutt, Greentown’s interim CEO, who replaced Kevin Knobloch after he announced that he would step down in July 2024 after less than a year in the role.

Greentown also named Naheed Malik its new CFO in January.

Timmeko Moore Love was named the first Houston general manager and senior vice president of Greentown Labs. According to LinkedIn, she left the role in January.

---

This article originally appeared on our sister site, EnergyCapitalHTX.com.

Houston foundation grants $27M to support Texas chemistry research

fresh funding

Houston-based The Welch Foundation has doled out $27 million in its latest round of grants for chemical research, equipment and postdoctoral fellowships.

According to a June announcement, $25.5 million was allocated for the foundation's longstanding research grants, which provide $100,000 per year in funding for three years to full-time, regular tenure or tenure-track faculty members in Texas. The foundation made 85 grants to faculty at 16 Texas institutions for 2025, including:

  • Michael I. Jacobs, assistant professor in the chemistry and biochemistry department at Texas State University, who is investigating the structure and thermodynamics of intrinsically disordered proteins, which could "reveal clues about how life began," according to the foundation.
  • Kendra K. Frederick, assistant professor in the biophysics department at The University of Texas Southwestern Medical Center, who is studying a protein linked to Parkinson’s disease.
  • Jennifer S. Brodbelt, professor in chemistry at The University of Texas at Austin, who is testing a theory called full replica symmetry breaking (fullRSB) on glass-like materials, which has implications for complex systems in physics, chemistry and biology.

Additional funding will be allocated to the Welch Postdoctoral Fellows of the Life Sciences Research Foundation. The program provides three-year fellowships to recent PhD graduates to support clinical research careers in Texas. Two fellows from Rice University and Baylor University will receive $100,000 annually for three years.

The Welch Foundation also issued $975,000 through its equipment grant program to 13 institutions to help them develop "richer laboratory experience(s)." The universities matched funds of $352,346.

Since 1954, the Welch Foundation has contributed over $1.1 billion for Texas-nurtured advancements in chemistry through research grants, endowed chairs and other chemistry-related ventures. Last year, the foundation granted more than $40.5 million in academic research grants, equipment grants and fellowships.

“Through funding basic chemical research, we are actively investing in the future of humankind,” Adam Kuspa, president of The Welch Foundation, said the news release. “We are proud to support so many talented researchers across Texas and continue to be inspired by the important work they complete every day.”

New Houston biotech co. developing capsules for hard-to-treat tumors

biotech breakthroughs

Houston company Sentinel BioTherapeutics has made promising headway in cancer immunotherapy for patients who don’t respond positively to more traditional treatments. New biotech venture creation studio RBL LLC (pronounced “rebel”) recently debuted the company at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago.

Rima Chakrabarti is a neurologist by training. Though she says she’s “passionate about treating the brain,” her greatest fervor currently lies in leading Sentinel as its CEO. Sentinel is RBL’s first clinical venture, and Chakrabarti also serves as cofounder and managing partner of the venture studio.

The team sees an opportunity to use cytokine interleukin-2 (IL-2) capsules to fight many solid tumors for which immunotherapy hasn't been effective in the past. “We plan to develop a pipeline of drugs that way,” Chakrabarti says.

This may all sound brand-new, but Sentinel’s research goes back years to the work of Omid Veiseh, director of the Rice Biotechnology Launch Pad (RBLP). Through another, now-defunct company called Avenge Bio, Veiseh and Paul Wotton — also with RBLP and now RBL’s CEO and chairman of Sentinel — invested close to $45 million in capital toward their promising discovery.

From preclinical data on studies in mice, Avenge was able to manufacture its platform focused on ovarian cancer treatments and test it on 14 human patients. “That's essentially opened the door to understanding the clinical efficacy of this drug as well as it's brought this to the attention of the FDA, such that now we're able to continue that conversation,” says Chakrabarti. She emphasizes the point that Avenge’s demise was not due to the science, but to the company's unsuccessful outsourcing to a Massachusetts management team.

“They hadn't analyzed a lot of the data that we got access to upon the acquisition,” explains Chakrabarti. “When we analyzed the data, we saw this dose-dependent immune activation, very specific upregulation of checkpoints on T cells. We came to understand how effective this agent could be as an immune priming agent in a way that Avenge Bio hadn't been developing this drug.”

Chakrabarti says that Sentinel’s phase II trials are coming soon. They’ll continue their previous work with ovarian cancer, but Chakrabarti says that she also believes that the IL-2 capsules will be effective in the treatment of endometrial cancer. There’s also potential for people with other cancers located in the peritoneal cavity, such as colorectal cancer, gastrointestinal cancer and even primary peritoneal carcinomatosis.

“We're delivering these capsules into the peritoneal cavity and seeing both the safety as well as the immune activation,” Chakrabarti says. “We're seeing that up-regulation of the checkpoint that I mentioned. We're seeing a strong safety signal. This drug was very well-tolerated by patients where IL-2 has always had a challenge in being a well-tolerated drug.”

When phase II will take place is up to the success of Sentinel’s fundraising push. What we do know is that it will be led by Amir Jazaeri at MD Anderson Cancer Center. Part of the goal this summer is also to create an automated cell manufacturing process and prove that Sentinel can store its product long-term.

“This isn’t just another cell therapy,” Chakrabarti says.

"Sentinel's cytokine factory platform is the breakthrough technology that we believe has the potential to define the next era of cancer treatment," adds Wotton.

View All Listings